文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

长链非编码RNA NEAT1,一种参与帕金森病病理生理过程的重要生物标志物。

LncRNA NEAT1, an Important Biomarker Involved in the Pathological and Physiological Processes of Parkinson's Disease.

作者信息

Chen Runsen, Zhang Yuxi, Shen Yang, Wu Kede, Mo Xuming, Yang Zhaocong

机构信息

Department of Cardiothoracic Surgery, Children's Hospital of Nanjing Medical University, Nanjing, 210008, China.

Animal Core Facility, Nanjing Medical University, Nanjing, 210008, China.

出版信息

J Neuroimmune Pharmacol. 2025 Jan 14;20(1):7. doi: 10.1007/s11481-024-10168-0.


DOI:10.1007/s11481-024-10168-0
PMID:39808217
Abstract

Parkinson's disease (PD) is a complex progressive neurodegenerative disorder and the pathogenesis and treatment methods are unknown. This aim is to investigate the effects of long non coding RNA NEAT1 (LncRNA NEAT1) on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease (PD). Immunoprecipitation and western blot were used to search for the effects of LncRNA NEAT1 on PD. Tyrosine hydroxylase (TH) and brain derived neurotrophic factor (BDNF) were evaluated in substantia nigra (SN) region of the brain by immunohistochemical staining. Compared with the control group, the relative expression level of LncRNA NEAT1 in the MPTP group was significantly increased. LncRNA NEAT1 is negatively correlated with miR-376b-3p. LncRNA NEAT1 significantly increased oxidative stress, neuroinflammation along with enhanced neurotrophic potential via NLR family Pyrin domain protein 3 (NLRP3) pathway. In conclusion, these results indicated that LncRNA NEAT1 participated in the pathophysiological of PD and its mechanism via the miR-376b-3p/NLRP3 signaling pathway.

摘要

帕金森病(PD)是一种复杂的进行性神经退行性疾病,其发病机制和治疗方法尚不清楚。本研究旨在探讨长链非编码RNA NEAT1(LncRNA NEAT1)对1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱导的帕金森病(PD)的影响。采用免疫沉淀和蛋白质印迹法研究LncRNA NEAT1对PD的影响。通过免疫组织化学染色评估脑黑质(SN)区域的酪氨酸羟化酶(TH)和脑源性神经营养因子(BDNF)。与对照组相比,MPTP组中LncRNA NEAT1的相对表达水平显著升高。LncRNA NEAT1与miR-376b-3p呈负相关。LncRNA NEAT1通过NLR家族含pyrin结构域蛋白3(NLRP3)途径显著增加氧化应激、神经炎症,并增强神经营养潜能。总之,这些结果表明LncRNA NEAT1通过miR-376b-3p/NLRP3信号通路参与PD的病理生理过程及其机制。

相似文献

[1]
LncRNA NEAT1, an Important Biomarker Involved in the Pathological and Physiological Processes of Parkinson's Disease.

J Neuroimmune Pharmacol. 2025-1-14

[2]
lncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson's disease by impairing miR-374c-5p.

Acta Biochim Biophys Sin (Shanghai). 2021-7-5

[3]
LncRNA NEAT1 Regulates the Development of Parkinson's Disease by Targeting AXIN1 Via Sponging miR-212-3p.

Neurochem Res. 2021-2

[4]
NEAT1 Decreasing Suppresses Parkinson's Disease Progression via Acting as miR-1301-3p Sponge.

J Mol Neurosci. 2021-2

[5]
MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson's disease mouse model.

J Cell Physiol. 2019-6-24

[6]
Angiotensin-(1-7) relieves behavioral defects and α-synuclein expression through NEAT1/miR-153-3p axis in Parkinson's disease.

Aging (Albany NY). 2024-10-17

[7]
LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis.

Behav Brain Res. 2022-8-5

[8]
Promotes Parkinson's Disease via Modulating Pathway.

Hum Gene Ther. 2020-12

[9]
5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.

Free Radic Biol Med. 2019-1-5

[10]
NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress.

FASEB J. 2019-7-17

引用本文的文献

[1]
Emerging Role of Long, Non-Coding RNA Nuclear-Enriched Abundant Transcript 1 in Stress- and Immune-Related Diseases.

Int J Mol Sci. 2025-5-6

本文引用的文献

[1]
Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.

Acta Neuropathol Commun. 2016-4-22

[2]
Salidroside ameliorates arthritis-induced brain cognition deficits by regulating Rho/ROCK/NF-κB pathway.

Neuropharmacology. 2016-4

[3]
Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model.

Eur J Neurosci. 2016-1

[4]
Rho Kinases in Health and Disease: From Basic Science to Translational Research.

Pharmacol Rev. 2015-10

[5]
Anti-Asthmatic Effects of Ginsenoside Rb1 in a Mouse Model of Allergic Asthma Through Relegating Th1/Th2.

Inflammation. 2015-10

[6]
Effect and reporting bias of RhoA/ROCK-blockade intervention on locomotor recovery after spinal cord injury: a systematic review and meta-analysis.

JAMA Neurol. 2014-1

[7]
Rho-associated coiled-coil kinase (ROCK) signaling and disease.

Crit Rev Biochem Mol Biol. 2013-4-19

[8]
Rho-kinase inhibitor, fasudil, prevents neuronal apoptosis via the Akt activation and PTEN inactivation in the ischemic penumbra of rat brain.

Cell Mol Neurobiol. 2012-5-3

[9]
Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.

Neurobiol Dis. 2012-4-19

[10]
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.

Lancet Neurol. 2009-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索